How Can We Help You?


Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Cervical Cancer Trials

Select Clinical Trial

Protocol Number: AGENUS C750-01/GOG 3028 Cervical

Protocol Title: A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (anti-PD-1) as a Monotherapy or Combination Therapy with AGEN1884 (anti-CTLA4) or with Placebo in Women with Recurrent Cervical Cancer (Second Line).

Eligibility: Patient population 18 years and older with confirmed cervical cancer that has already been treated with other therapies and your cancer has recurred or is not responding to those treatments.

Contact Information: (910) 715-2200





Clara McLean House
Make a Donation
News & Events